KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Health Canada has approved a new indication for PREVYMIS® (letermovir) for the prophylaxis of cytomegalovirus… Read More
Approval is based on the Phase 3 KEYNOTE-859 trial KIRKLAND, QC – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted approval… Read More
VANCOUVER, BC – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a leader in the research, development, manufacturing, and commercialization of rare cannabinoids and proprietary cannabinoid analogs, announced the… Read More
Selected by employees, GSK welcomes three new philanthropic partners: Second Harvest, FIRST Robotics and Les Scientifines. Expansion into new philanthropic areas broadens company’s existing support of community health, emergency preparedness and disaster… Read More
